Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by longondmxon Jan 06, 2009 1:54pm
339 Views
Post# 15685972

RE: RE: RE: World Changes - AGAIN

RE: RE: RE: World Changes - AGAIN

I do not doubt that the price WILL go up from here - what a great buying time.  Anyone that thinks otherwise needs to step back and realize what is about to happen in the next 6 months. 

 1. We will get a new submission to the FDA in the next few weeks.  --> price increase

2. There will be a constant building of anticipation of an FDA approval starting a couple of months after submission and lasting until a decision is made --> price increase

3. we may get a marketing partner announced before FDA announcement (although that may be unlikely until after FDA approval)

4. we may get an indication of the California company (FQUBED sp?) technology that is being looked at by P&G (or so we think is P&G)- -> price increase

I see little downside risk in the next 6 months (other than an FDA decline - which frankly, should not happen - and the recent Labopharm decision helped solidify my belief that we WILL get approved this time around).  And I see a lot of upside risk.  Just wish I was just getting into this stock today for the first time.

Bullboard Posts